Dual Immune Check Point Blockade in MGMT-Unmethylated Newly Diagnosed Glioblastoma: NRG Oncology BN007, a Randomized Phase II/III Clinical Trial

Publication Date

2025

Content Type

article

PubMed ID:

40779733

Additional Authors:

Additional Authors and Institutional Affiliations

This document is currently not available here.

Share

COinS